Meeting Mic

Healio
  • 0.0 (0)
  • Medicine
  • Updated Weekly

While annual major scientific meetings are the venue to stay up-to-date in your clinical area, it is near impossible to attend all breaking news sessions. Through interviews with experts, Healio's Meeting Mic provides a post-meeting wrap-up of the most important content that listeners can consume on-the-go.

  1. Breast cancer highlights from ASCO 2026

    2 days ago

    Breast cancer highlights from ASCO 2026

    In this episode of Meeting Mic, we bring you pearls and perspectives in breast cancer from ASCO Annual Meeting. In an interview, Jame Abraham, MD, discusses the DESTINY-Breast05 study, as well as clinical and demographic risk factors for interstitial lung disease and radiation pneumonitis. Next, Shimoli Barot, MD, discusses results from the phase 3 lidERA BC clinical trial of premenopausal vs. postmenopausal women with breast cancer. Sara A. Hurvitz, MD, FACP, provides an overview of the ASCENT-03 study of a subset of women with triple-negative breast cancer. And, Sherry Shen, MD, talks about a presentation on mutational signatures and related outcomes in metastatic invasive lobular carcinoma. Read the full coverage here: VIDEO: Clinicians 'should continue to pay attention' to T-DXd side effects in breast cancer Untch M, et al. Abstract 516. Presented at: ASCO Annual Meeting; May 29-June 2, 2016; Chicago. VIDEO: Giredestrant improves breast cancer survival, regardless of menopause status Healio Interviews VIDEO: Sacituzumab govitecan delays subsequent therapy in breast cancer subset Hurvitz SA. Abstract 1001. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago. VIDEO: Survival in metastatic invasive lobular carcinoma differs by mutational signature Shen S, et al. Abstract 1141. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago. 'Reassuring': Omitting full axillary dissection does not worsen survival in breast cancer De Boniface J, et al. Abstract LBA503. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago. Abraham reports research funding from AstraZeneca/Daiichi Sankyo and Pfizer. Barot and Shen report no relevant financial disclosures. Hurvitz reports research funding from AstraZeneca/Daiichi Sankyo, Novartis and Stemline Therapeutics; and advisory or consulting roles with Akari Therapeutics, ALX Oncology, Bayer, BeOne Medicines, Blueprint Medicines, Boundless Bio, BriaCell, BridgeBio Pharma, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly Oncology, Ellipses Pharma, EMBioSys, Gilead Sciences, Jazz Pharmaceuticals, Luminate Medical, Mersana Therapeutics, Myricx Bio, Prelude Therapeutics and Roche.

    16 min
  2. Metastatic breast cancer highlights from ASCO 2026

    29 June

    Metastatic breast cancer highlights from ASCO 2026

    In this episode of Meeting Mic, we bring you pearls and perspectives in metastatic breast cancer from the American Society of Clinical Oncology 2026. In an interview, Shimoli Barot, MD, discusses a genomic test which could be used to identify patients with ER-positive, HER2-negative breast cancer who may be able to avoid chemotherapy. Next, Erika P. Hamilton, MD, discusses the HER2-CLIMB05 trial for patients with HER2-positive metastatic breast cancer. And, Sherry Shen, MD, discusses lifestyle and survivorship for patients with breast cancer, specifically with GLP-1 use. Read the full coverage here: VIDEO: Genetic test helps identify patients with breast cancer who may avoid chemotherapy Source: Healio Interviews VIDEO: Tucatinib plus trastuzumab, pertuzumab safe for HER2-positive breast cancer Source: Hamilton EP. Abstract 1005. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago. VIDEO: Less weight loss, improved survival for GLP-1 use in women with breast cancer Source: Shen S. Optimizing breast cancer survivorship: Addressing lifestyle, weight management, and psychological health. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago. 'Critically important': Upfront sacituzumab govitecan combo benefits breast cancer subset Source: Kalinsky K, et al. Abstract LBA1000. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago. 'Real value': Remote program significantly improves physical function in breast cancer Source: Ligibel JA, et al. Abstract 12010. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago. Barot and Shen report no relevant financial disclosures. Hamilton reports receiving research funding from Abbvie, Accutar Biotechnology, Artios, Arvinas, AstraZeneca, AtlasMedx, BeiGene, BeOne Medicines, Bicycle Therapeutics, Biohaven Pharmaceuticals, BioNTech, Compugen, Cullinan, Daiichi Sankyo, Dantari, Day One Biopharmaceuticals, Duality Biologics, Ellipses Pharma, Elucida Oncology, Exelixis, FujiFilm, Genmab, Gilead Sciences, H3 Biomedicine, Iambic Therapeutics, Immunogen, Inspirna, InventisBio, Jacobio, Jazz Pharmaceuticals, K-Group Beta, Kind Pharmaceuticals, Lilly, Loxo Oncology, Mabspace Biosciences, Mabwell Bioscience, Marengo Therapeutics, MediLink Therapeutics, Merck, Mersana, Novartis, Olema, Orinove, Orum Therapeutics, Pfizer, Pionyr Immunotherapeutics, Prelude Therapeutics, Profound Bio, Regeneron, Relay Therapeutics, Rgenix, Roche/Genentech, SeaGen, Shattuck Labs, Simcha Therapeutics, Stemline Therapeutics, Sutro, Systimmune, Taiho, Tesaro, TheRas, Treadwell Therapeutics, Verastem, Xadcera Biopharmaceutical and Zymeworks; and consulted or advised for ADC Therapeutics, Arvinas, AstraZeneca, BeOne Medicines, BicycleTx, BioNTech, Boehringer Ingelheim, Boundless Bio, Bristol-Myers Squibb, Daiichi Sankyo, Gilead Sciences, Halda Therapeutics, Hexagon Bio, Immunome, Incyclix Bio, Janssen, Jazz Pharmaceuticals, Lilly, Merck, Mersana Therapeutics, Novartis, Pfizer, Precede Biosciences, Pyxis Oncology, Rigel Pharmaceuticals, Roche/Genentech, Samsung Bioepis, Shorla Pharma and Stemline Therapeutics.

    14 min
  3. ASCO 2026 with Oncology Insider

    23 June

    ASCO 2026 with Oncology Insider

    In this episode of Meeting Mic, Mark Leiser, Healio's Oncology Insider, joins Shikha Jain, MD, to discuss top presentations, as well as pearls and perspectives from ASCO Annual Meeting. ·       Daraxonrasib offers 'transformational' benefit in metastatic pancreatic cancer ·       GLP-1s demonstrate 'large' & 'consistent' protective effects against cancer metastases ·       Trial of early cancer detection test misses primary endpoint; secondary data 'promising' ·       'This matters': Hem/onc fellows embrace AI but lack formal training to guide its use ·       Hem/onc 'bootcamp' significantly improves fellows' knowledge, clinical confidence ·       Immunotherapy combination may improve outcomes in unresectable liver cancer ·       Abemaciclib may be new standard for 'challenging' sarcoma subtype For more of the latest breaking news in oncology, be sure to visit Oncology Insider. We'd love to hear from you! For more from Dr. Jain, follow her on X: @ShikhaJainMD and on Instagram: @shikhajainmd. For more from Leiser, follow him on X: @_MarkLeiser or on LinkedIn. Jain and Leiser report no relevant financial disclosures.

    29 min

  4. 1 June

    Highlights from ARVO 2026

    In this episode of Meeting Mic, we bring you pearls and perspectives from the Association of Vision and Research in Ophthalmology 2026. Jason Greenfield, MD, MBA, Alon Harris, MS, PhD, FARVO, and Yash Lahoti spoke with Healio about their study, which was designed to look at some of the unknown risk factors for glaucoma. 00:37 Next, Michael Zhu, a medical student at Duke University School of Medicine, told Healio about his presentation about retina imaging and how it may reveal links to Parkinson's disease. 06:12 And, Iris Fang-Yu Hu, MD, discusses her presentation on how using visual prompts helped improve glaucoma detection by a large language model. 08:35 Top headlines from the meetings. 09:31 Read the full coverage here: Glaucoma, hypertension may be linked to dementia risk Source: Greenfield J, et al. Artificial intelligence ready and exploratory atlas for diabetes insights: The association between glaucoma, hypertension, and cognitive performance. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver. Imaging reveals link between inner nuclear layer thickness, Parkinson's disease Source: Zhu M, et al. Macular retinal layer thickness in early Parkinson's disease. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver. Reference images help AI model detect glaucoma Source: Hu I, et al. Providing reference images to LLMs improves glaucoma detection from fundus photos. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver. Smoking may be modifiable risk factor for myopia-related vision loss Source: Flitcroft I, et al. Smoke gets in your eyes: Evidence that smoking is the first modifiable risk factor for myopia-related vision impairment. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver. Thyroid eye disease shows long-term progression in real-world dataset Source: Ramesh S, et al. Disease progression in thyroid eye disease: Findings from a large real-world study in the United States. Presented at: Association for Research in Vision and Ophthalmology meeting; May 3-7, 2026; Denver.

    14 min
  5. Highlights from the American Academy of Neurology Annual Meeting 2026

    6 May

    Highlights from the American Academy of Neurology Annual Meeting 2026

    In this episode of Meeting Mic, we bring you pearls and perspectives from the American Academy of Neurology (AAN) Annual Meeting 2026. Christopher Lock, MD, discusses key takeaways from the meeting. 00:12 Claire Delpirou Nouh, MD, highlights the meeting's major discussions and presentations. 05:27 Top headlines from the meetings. 08:42 Read the full coverage here: Improved mortality outweighs cognitive risks in GLP-1 analog use Source: Thorman IB, et al. Long-term risk of cognitive impairment with GLP-1 analogues in older adults with type 2 diabetes mellitus. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego. Prolonged seizures negatively impact productivity, quality of life in patients, caregivers Source: Trinka E, et al. Loss of productivity, seizure worry, and patient and caregiver quality of life associated with prolonged seizures: Results from a global real-world point-in-time study. Presented at: American Academy of Neurology Annual Meeting; April 18-22, 2026; Chicago. Improvements in biological age linked to lower stroke risk, healthier brains Source: Rivier C, et al. Improvements in biological age acceleration lead to better neuroimaging, clinical and cognitive markers of brain health. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego.

    17 min
  6. Highlights from Miami Breast Cancer Conference 2026

    25 Mar

    Highlights from Miami Breast Cancer Conference 2026

    In this episode of Meeting Mic, we bring you pearls and perspectives from Miami Breast Cancer Conference 2026. Paolo Tarantino, MD, PhD, discusses key takeaways from the meeting. :19 Paolo Tarantino, MD, PhD, highlights the meeting's major discussions and presentations. 3:02 Hope S. Rugo, MD, provides an overview of the inspiring and revelatory information presented at the conference. 4:41 Read the full coverage here: https://www.healio.com/news/hematology-oncology/20260317/video-oncology-education-key-to-understanding-growing-data-in-breast-cancer-treatment https://www.healio.com/news/hematology-oncology/20260317/video-discussions-on-her2positive-breast-cancer-treatment-may-alter-way-of-practicing  https://www.healio.com/news/hematology-oncology/20260317/video-trastuzumab-deruxtecan-in-adjuvant-setting-may-be-preferred-in-breast-cancer https://www.healio.com/news/hematology-oncology/20260325/video-breast-cancer-conference-fuses-data-specialties-in-continuum-of-patient-care https://www.healio.com/news/hematology-oncology/20260325/video-keynote-speaker-inspires-others-to-push-beyond-the-barriers-in-breast-cancer

    9 min
  7. Highlights from SABCS 2025

    12/12/2025

    Highlights from SABCS 2025

    In this episode of Meeting Mic, we bring you the highlights and insights from the San Antonio Breast Cancer Symposium 2025, as well as Healio's top headlines from the meeting. Amy Comander, MD, DipABLM, FACLM, MSCP, highlights presentations at this year's meeting. :26 Jun J. Mao, MD, MSCE, discusses results from a phase 2 trial surrounding acupuncture for breast cancer. 1:50 Amanda M. Woodworth, MD, FACS, CPE, describes a digital toolkit for advancing risk-informed breast cancer screening. 4:41 Read the full coverage here: Advancements in Breast Cancer, Lifestyle Medicine and A Preview of SABCS with Amy Comander, MD Sentinel node biopsy pioneer to receive William L. McGuire Memorial Lecture Award Tucatinib regimen delays disease progression in advanced HER2-positive breast cancer Disclosures: Comander reports no relevant financial disclosures. Healio could not confirm financial disclosures for Mao and Woodworth at the time of publishing.

    11 min
  8. Highlights from NEI 2025

    24/11/2025

    Highlights from NEI 2025

    In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 Neuroscience Educational Institute (NEI) Annual Congress. David W. Goodman, MD, LFAPA, discusses his presentation about ADHD in adults including diagnosis, treatment and the current challenges. :22 Katherine Dahlsgaard, PhD, ABPP, talks about her presentations on behavioral interventions for sleepy adolescents as well as the challenges physicians face in prescribing psychiatric medicines. 5:43 Kari L. Franson, PharmD, PhD, BCPP, FNAP, highlights her presentations on the current status of prescription digital therapeutics and the practice of de-prescribing psychiatric medicines.  17:28 Disclosures: Goodman reports receiving honoraria from Clinical Care Options, HCPLive, Medscape, Neuroscience Education Institute and World Federation for ADHD. Healio was unable to confirm relevant disclosures for Dahlsgaard or Franson at the time of publication.

    26 min
See All (30)

About

While annual major scientific meetings are the venue to stay up-to-date in your clinical area, it is near impossible to attend all breaking news sessions. Through interviews with experts, Healio's Meeting Mic provides a post-meeting wrap-up of the most important content that listeners can consume on-the-go.

Information

  • Channel
    Healio
  • Creator
    Healio
  • Years Active
    2020 - 2026
  • Episodes
    30
  • Rating
    Clean
  • Show Website
    Meeting Mic

More From Healio